付表ⅠA 指定を受けた医薬品の有効成分
号(Sub-heading) 品名 Description 2906.29 フルメシノール flumecinol 2906.29 メタグリコドール metaglycodol 2906.29 フェナグリコドール phenaglycodol
Download 付表ⅠA 指定を受けた医薬品の有効成分
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
The following cargo information ... - 税関 Japan …
www.customs.go.jpThe following cargo information shall be filed under the Advance Filing Rules on Maritime Container Cargo Information. Appendix 3 Data Elements to Be Filed (1)
Information, Maritime, Graco, Container, On maritime container cargo information
AEO program - 税関 Japan Customs
www.customs.go.jpAEO program (Authorized Economic Operator) Customs & Tariff Bureau Ministry of Finance, Japan
Customs Form C No.5360-B CUSTOMS DECLARATION
www.customs.go.jp(-A-) Japan Customs Customs Form C No.5360-B Flight No./Name of Vessel ( CUSTOMS DECLARATION Declaration of Personal Effects and Unaccompanied Articles Please fill in the following information and submit to Customs.
Declaration, Japan, Custom, Customs declaration, Japan customs customs, Customs declaration declaration
タイ協定原産地証明書の記入要領 原産地証明書は …
www.customs.go.jp財務省関税局業務課 1. Goods consigned from (Exporter’s business name, address, country) Reference No. CERTIFICATE OF ORIGIN (Combined declaration and certificate)
2.運送要件証明書について - customs.go.jp
www.customs.go.jp説明事項 1.原産地証明書の記載事項及び審査 2.運送要件証明書について 3.税関における手続き 41
Rules of Origin under Japan’s EPAs - 税関 Japan …
www.customs.go.jpRules of Origin under Japan’s EPAs Requests concerning translation, reproduction and adaptation should be addressed to Customs and Tariff Bureau, Ministry of …
Rules, Under, Japan, Custom, Origin, Rules of origin under japan s epas, Epas
EPA 原産地規則マニュアル - customs.go.jp
www.customs.go.jpepa 原産地規則マニュアル 平成30年6月 東京税関業務部総括原産地調査官 関税局業務課監修
加硫したゴムの分析 - customs.go.jp
www.customs.go.jp関税中央分析所報 第46号 71 3.2 ラマン分光法 分以降には、 加硫前後を比較したSBR のラマンスペクトルをFig.4 に示す。
特定輸出者一覧 (Authorized Exporter) - customs.go.jp
www.customs.go.jpクボタマシナリートレーディング株式会社 KUBOTA Machinery Trading Co.,Ltd. 4120001037991 クラリオン株式会社 Clarion Co.,Ltd. 6030001017472
特例輸入者一覧 (Authorized Importer) - customs.go.jp
www.customs.go.jp特 例 輸 入 者 名 英 名 法人番号 日本石鹸株式会社 nihon soap co.,ltd. 8122001019660 日本電産株式会社 nidec corporation 9130001002387
Related documents
DRUGS AND COSMETICS (2 ND AMENDMENT) RULES, 2006 …
rajswasthya.nic.inDRUGS AND COSMETICS (2 ND AMENDMENT) RULES, 2006 MINISTRY OF HEALTH AND FAMILYWELFARE (Department of Health) NOTIFICATION New Delhi, the 16th March, 2006 G.S.R. 160(E).– Whereas a draft of certain rules further to amend the Drugs and
Health, 2006, Ministry, 2006 ministry of health and familywelfare, Familywelfare
APIs – CEP / EDMF / Technical package available
www.fa-pharma.comapis – cep / edmf / technical package available product name documentation status abacavir sulphate edmf ctd acamprosate calcium edmf ctd acarbose cep acebutolol hcl cep aceclofenac cep acemetacin edmf ctd aciclovir cep adapalene edmf ctd adefovir dipivoxil edmf ctd afloqualone edmf ctd albuterol sulphate edmf ctd alendronic acid sodium salt (sodium alendronate) cep ...
Technical, Packages, Available, Calcium, Cep edmf technical package available, Edmf
Д О К Л А Д по чл.92а, ал.5 от ЗОП
www.mbalmontana.comСъгласно обявения критерий за оценка „най-ниска цена”, в случая класиране не може да бъде направено – подадена е една оферта.
DOXIUM 500 OM Pharma - Modern Medicine
www.meppo.comDOXIUM 500 - p.2/3 ml on the average after 6 hours (tmax).Twenty four hours after intake blood level is about 3 μg/ml. The rate of protein-binding is 20 - 25%.
BRAND / GENERIC NAME FORMULATION PRESENTATION
www.wallacepharma.comBRAND / GENERIC NAME FORMULATION PRESENTATION CARDIOVASCULAR Antianginal MONICOR TABLETS Each uncoated tablet contains: 25x10's Blister Isosorbide Mononitrate Tablets BP Isosorbide-5-Mononitrate B.P. 20mg 1000's HDPE Container
Name, Presentation, Generic, Brand, Formulation, Brand generic name formulation presentation
CALCIUM DOBESILATE – THE VASOACTIVE DRUG
www.wallacepharma.com1 DOBEST CALCIUM DOBESILATE – THE VASOACTIVE DRUG INTRODUCTION Calcium dobesilate is a vasoactive drug with presumed effects on endothelial integrity,